Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 0.3138
-17.8 %
$ 16.4 M
Market Cap
-2.24
P/E
ENZ - COST OF REVENUE
Cost of Revenue ENZ - Enzo Biochem, Inc.
17.3 M
LAST VALUE
-48.49%
2 YEAR CAGR
-21.49%
5 YEAR CAGR
-10.82%
10 YEAR CAGR